{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T06:42:10Z","timestamp":1776062530963,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T00:00:00Z","timestamp":1589068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.vaccine.2020.05.002","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T23:45:05Z","timestamp":1590104705000},"page":"4524-4528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The pseudorabies virus R2 non-neuroinvasive vaccine: A proof-of-concept study in pigs"],"prefix":"10.1016","volume":"38","author":[{"given":"Gary E.","family":"Pickard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Brodersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia J.","family":"Sollars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.05.002_b0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-micro-092611-150051","article-title":"Herpesvirus transport to the nervous system and back again","volume":"66","author":"Smith","year":"2012","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2020.05.002_b0010","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1016\/j.vaccine.2017.10.084","article-title":"Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017","volume":"37","author":"Gottlieb","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.002_b0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coi.2019.02.009","article-title":"Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine","volume":"59","author":"Heinerman","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2020.05.002_b0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.coi.2019.02.005","article-title":"Understanding the immunology of the Zostavax shingles vaccine","volume":"59","author":"Sullivan","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2020.05.002_b0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fnagi.2018.00324","article-title":"Corroboration of a major role for herpes simplex virus type 1 in Alzheimer\u2019s Disease","volume":"10","author":"Itzhaki","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.vaccine.2020.05.002_b0030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fimmu.2015.00208","article-title":"Deciphering human cell-autonomous anti-HSV immunity in the central nervous system","volume":"6","author":"Lafaille","year":"2015","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.05.002_b0035","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/MMBR.69.3.462-500.2005","article-title":"Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine","volume":"69","author":"Pomeranz","year":"2005","journal-title":"Micro Mol Biol Rev"},{"key":"10.1016\/j.vaccine.2020.05.002_b0040","article-title":"The round trip model for severe herpes zoster caused by live attenuated varicella vaccine virus","volume":"jmv.25664","author":"Grose","year":"2020","journal-title":"J Med Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2020.05.002_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006741","article-title":"The pUL37 tegument protein guides alpha-herpesvirus retrograde axonal transport to promote neuroinvasion","volume":"13","author":"Richards","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2020.05.002_b0050","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1128\/JVI.00163-14","article-title":"Crystal structure of the herpesvirus inner tegument protein UL37 supports its essential role in control of viral trafficking","volume":"88","author":"Pitts","year":"2014","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2020.05.002_b0055","doi-asserted-by":"crossref","first-page":"e01244","DOI":"10.1128\/JVI.01244-17","article-title":"Crystal structure of the N-terminal half of the traffic controller UL37 from herpes simplex virus 1","volume":"91","author":"Koenigsberg","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.05.002_b0060","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1073\/pnas.080502497","article-title":"A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis","volume":"97","author":"Smith","year":"2000","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2020.05.002_b0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1099\/vir.0.036145-0","article-title":"Fusion of a fluorescent protein to the pUL25 minor capsid protein pf pseudorabies virus allows live-cell capsid imaging with negligible impact on infection","volume":"93","author":"Bohannon","year":"2012","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.002_b0070","doi-asserted-by":"crossref","first-page":"e02058","DOI":"10.1128\/JVI.02058-16","article-title":"Age-dependent differences in pseudorabies virus neuropathogenesis and associated cytokine expression","volume":"91","author":"Verpoest","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.05.002_b0075","article-title":"Pseudorabies virus. Swine Health Information Center and Center for Food Security and Public","author":"Leedom Larson","year":"2016","journal-title":"Health"},{"key":"10.1016\/j.vaccine.2020.05.002_b0080","first-page":"42","article-title":"Experimental reduction of virulence of Aujeszky\u2019s disease virus (in Hungarian)","volume":"16","author":"Bartha","year":"1961","journal-title":"Magyar Allatorvosok Lapja"},{"key":"10.1016\/j.vaccine.2020.05.002_b0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vetmic.2016.11.019","article-title":"Vaccines against pseudorabies virus (PrV)","volume":"206","author":"Freuling","year":"2017","journal-title":"Vet Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.05.002_b0090","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/1040638715593599","article-title":"Outbreak of variant pseudorabies virus in Bartha-K61-vaccinated piglets in central Shandong Province","volume":"27","author":"Hu","year":"2015","journal-title":"China. J Vet Diag Invest"},{"key":"10.1016\/j.vaccine.2020.05.002_b0095","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.5785","article-title":"Epidemiological and genetic characteristics of swine pseudorabies virus in mainland China between 2012 and 2017","volume":"6","author":"Sun","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.vaccine.2020.05.002_b0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.vetmic.2015.12.008","article-title":"Control of swine pseudorabies in China: opportunities and limitations","volume":"183","author":"Sun","year":"2016","journal-title":"Vet Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20306083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20306083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:44:09Z","timestamp":1759401849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20306083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":20,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0264410X20306083"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pseudorabies virus R2 non-neuroinvasive vaccine: A proof-of-concept study in pigs","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}